about
Virus like particle-based vaccines against emerging infectious disease viruses.Hendra virus and Nipah virus animal vaccines.Peri-exposure protection against Nipah virus disease using a single-dose recombinant vesicular stomatitis virus-based vaccine.Dissection of influenza A virus M1 protein: pH-dependent oligomerization of N-terminal domain and dimerization of C-terminal domainHepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responsesRecombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge.Mammalian Cell-Derived Respiratory Syncytial Virus-Like Particles Protect the Lower as well as the Upper Respiratory TractThe immune response to Nipah virus infection.Two polar residues within C-terminal domain of M1 are critical for the formation of influenza A Virions.Respiratory nanoparticle-based vaccines and challenges associated with animal models and translationSingle-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.Construction and characterization of virus-like particles: a review.Bioengineering virus-like particles as vaccines.Henipavirus Encephalitis: Recent Developments and Advances.Nipah virion entry kinetics, composition, and conformational changes determined by enzymatic virus-like particles and new flow virometry tools.Early Activation of Primary Brain Microvascular Endothelial Cells by Nipah Virus Glycoprotein-Containing Particles.Virus-like particle-based countermeasures against Rift Valley fever virus.Cytoplasmic Motifs in the Nipah Virus Fusion Protein Modulate Virus Particle Assembly and Egress.A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model.Screening and structure-based modeling of T-cell epitopes of Nipah virus proteome: an immunoinformatic approach for designing peptide-based vaccine.
P2860
Q30249025-5192F1B7-6824-4182-BD38-0C1BEA215172Q30387821-07397CE9-45E3-4137-8E05-CE924A4BA033Q33894405-30E54FCB-1CED-42EB-8BAD-E71A436F08EAQ34289065-D17C5697-F46F-4871-AB08-41BC489686E4Q34455275-3B5FFB15-1119-4D24-BEA2-4494260C4A0DQ34629595-DD50B438-8A80-4383-A302-69642A8B25FCQ35690781-9FB975C2-2A3C-485E-824E-97E46730F800Q36203198-B4290DC4-7541-45A7-8035-B9B3D167D6D2Q36380177-291AEC83-A924-4E48-958B-1C8D5D8E47F0Q36598433-CA353738-399C-4CBA-B91E-3F458A43566CQ36791009-5EF68A55-899A-465D-B76F-E7D30A86B15DQ38045834-CBA0DBF9-CB0C-4EEB-AAD2-3ADB8881BBBCQ38172045-FB0EF471-3C76-4A2A-AB3C-4148EA4F1DBFQ38567114-66D36D85-50DA-4C14-9777-89ADFE7603DBQ38951339-00497E91-2253-493F-BF93-EADF777136E8Q39605342-15787073-AA30-4FFB-A64A-F63CE0C356C6Q40254473-CFD577BE-B743-48E6-B1DA-44525C26CC4BQ40312239-558CCCF8-D55F-4BD5-A6B8-261D762F0686Q47140392-4CE62A21-711B-4880-8F3A-ACFAC49174D9Q54858962-027FE0DF-C67E-4174-94E7-CC46A9BCB19C
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Vaccine potential of Nipah virus-like particles
@ast
Vaccine potential of Nipah virus-like particles
@en
type
label
Vaccine potential of Nipah virus-like particles
@ast
Vaccine potential of Nipah virus-like particles
@en
prefLabel
Vaccine potential of Nipah virus-like particles
@ast
Vaccine potential of Nipah virus-like particles
@en
P2093
P2860
P1433
P1476
Vaccine potential of Nipah virus-like particles
@en
P2093
Christopher F Basler
Jennifer Barr
Linfa Wang
Michael Sherman
Pramila Walpita
P2860
P304
P356
10.1371/JOURNAL.PONE.0018437
P407
P577
2011-04-06T00:00:00Z